This test finds immune system chemicals, called antibodies, that target CCP (cyclic citrullinated peptide), which is present in about 60% to 70% of people with rheumatoid arthritis (RA). You could have these antibodies years before you get RA symptoms. This test can also predict cases of RA that could become severe.